Drugs / Prednisone Oral Tablet
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03315338 Background | Sep 2017 → Feb 2019 | — | Corcept Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prednisone Oral Tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03315338 ↗ |
| Route | Oral | “Standard release 1x20mg and 1x5mg (25mg total) dose, orally administered.” NCT03315338 ↗ |